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Background: The effect of intranasal oxygen and/or early reversal of xylazine with atipamezole on arterial
oxygenation in free-ranging moose (Alces alces) immobilized with etorphine-acepromazine-xylazine with a cross-sectional
clinical study on 33 adult moose was evaluated.
Moose were darted from a helicopter with 3.37 mg etorphine, 15 mg acepromazine and 75 mg xylazine. Intranasal oxygen
at a flow rate of 4 L/min and/or early reversal of xylazine with 7.5 mg atipamezole to improve oxygenation was evaluated,
using four treatment regimens; intranasal oxygen (n = 10), atipamezole intramuscularly (n = 6), atipamezole
intravenously (n = 10), or a combination of atipamezole intravenously and intranasal oxygen (n = 7). Arterial
blood was collected 7–30 minutes (min) after darting, and again 15 min after institution of treatment and
immediately analyzed using an i-STAT®1 Portable Clinical Analyzer.
Results: Before treatment the mean ± SD (range) partial pressure of arterial oxygen (PaO2) was 62 ± 17 (26–99)
mmHg. Twenty-six animals had a PaO2 < 80 mmHg. Ten had a PaO2 of 40–60 mmHg and three animals had a
PaO2 < 40 mmHg. Intranasal oxygen and intravenous administration of atipamezole significantly increased the
mean PaO2, as did the combination of the two. In contrast, atipamezole administered intramuscularly at the evaluated
dose had no significant effect on arterial oxygenation.
Conclusions: This study shows that intranasal oxygen effectively improved arterial oxygenation in immobilized moose,
and that early intravenous reversal of the sedative component, in this case xylazine, in an opioid-based immobilization
drug-protocol significantly improves arterial oxygenation.
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Research to improve moose management, health and wel-
fare often requires chemical immobilization. In Scandinavia
approximately 5,000 immobilizations of moose have been
carried out since 1984 for ecological studies and man-
agement purposes. Although capture mortality rates* Correspondence: mariannelian@gmail.com
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unless otherwise stated.for moose in Norway and Sweden have been low, from
0.5% - 1.0% [1], the non-lethal adverse effects of capture
and immobilization procedures have traditionally been
ignored. A recent study from Sweden showed that female
moose changed movement patterns for 4.5 days post
immobilization with opioid combinations [2]. Another
study demonstrated that moose cows immobilized during
the last three months of pregnancy gave birth to calves
with reduced postnatal survivorship [3].
Potent opioids or opioids in combination with seda-
tives are most commonly used to immobilize moose.
Etorphine, carfentanil and thiafentanil have all been used
successfully [4-7]. When opioids are used alone, moose. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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immobilized sufficiently for approach and handling.
These drugs are, however, major respiratory depres-
sants [8,9]. Hypoxemia is a known problem in wildlife
immobilization [10]. Inadequate oxygen delivery will
lead to tissue hypoxia causing cell damage to vital tis-
sues like brain, myocardium, kidneys and liver [11,12].
Markedly decreased arterial oxygen partial pressure
(PaO2) levels indicating severe hypoxemia has been doc-
umented in several wildlife species during immobilization.
This seems to be most evident in wildlife species immobi-
lized with opioids, with reported PaO2 values as low as
10 mmHg in rhebok (Pelea capreolus) [8] and <40 mmHg
in species such as North American elk (Cervus canadensis),
white rhinoceros (Ceratotherium simum), white-tailed deer
(Odocoileus virginianus), impala (Aepyceros melampus),
black rhinoceros (Diceros bicornis) and wood bison
(Bison bison athabascae) [13-19].
Moose immobilized with etorphine, xylazine and ace-
promazine demonstrated severe hypoxemia, with the
lowest PaO2 at 36 mmHg, and marked acidemia (pH <
7.20) [9], emphasizing the need for research into preven-
tion of hypoxemia in immobilized moose. Nasal oxygen
insufflation has been shown to alleviate hypoxemia asso-
ciated with chemical immobilization in several wild un-
gulate species [14-17,20], but to our knowledge, has not
previously been evaluated in free-ranging moose. A com-
bination of etorphine, acepromazine and xylazine has been
used for immobilization of moose in Sweden since 1979
[1,21]. Opioids and alpha-2 adrenoceptor agonists are
respiratory depressant drugs [12]. Further, xylazine is a
vasoconstrictor, resulting in bradycardia, reduced car-
diac output and a biphasic blood pressure response.
The biphasic blood pressure response leads to a transi-
ent hypertension followed by a prolonged hypotension
[22]. Complete reversal of the etorphine would end the
immobilization, whereas reversal of the xylazine was
hypothesized to improve respiration while maintaining
immobilization. Evans et al. [9] conducted a physio-
logical evaluation of free-ranging moose immobilized
with this drug protocol in Sweden. They found severe
hypoxemia in all animals immediately after recum-
bency, and found no improvement in PaO2 values in the
second sample collected after 15 minutes of down time. In
this study we evaluated intranasal oxygen insufflation and
partial reversal of the immobilization protocol using atipa-
mezole, as measures against hypoxemia in moose immobi-
lized with etorphine, acepromazine and xylazine. Based on
the study done in 2012, we did not find it ethical to in-
clude a control group receiving no treatment [9].
Methods
The study was conducted during February 2012 in Öster
Malma, Södermans län (58.95° N, 17.16° E) and Växjö,Kronobergs län (56.87° N, 14.80° E), Sweden. Both loca-
tions have altitudes less than 170 m above sea level.
Thirty female and three male moose, 1–18 years old
captured for collaring and biometrics were sampled. Ini-
tially only females were included. However, both genders
were included in the last treatment group (the combin-
ation of intranasal oxygen and atipamezole intraven-
ously), to increase the sample size for this group. Only
animals sufficiently immobilized (sternal recumbency,
staying down when approached) with one dart were in-
cluded in the study. Animals were aged based on tooth
wear [23]. Ambient temperature and barometric pres-
sure (PB) were recorded. All captures had ethical approval
from the Ethical Committee on Animal Experiments in
Umeå, Sweden (Umeå Djurförsöksetiska Nämnd), ethical
permit number DNR A 50–12.
The drug mixture was made by adding 10 mL Large
Animal Immobilon® (Novartis Animal Health, Litlington,
UK, 2.25 mg/mL etorphine and 10 mg/mL aceproma-
zine) to one vial of Rompun® dry powder (xylazine, Bayer
AG, Leverkusen, Germany, 500 mg). Darts were loaded
with1.5 mL of the mixture, resulting in doses of 3.37 mg
etorphine, 15 mg acepromazine and 75 mg xylazine.
Moose were located using a helicopter and darted with
3-mL Dan inject darts with 2.0 x 40-mm barbed needles
with side-ports, in gluteal or epaxial muscles with a CO2
powered rifle (Dan-Inject, Børkop, Denmark) from an
estimated distance of three to ten meters. Needle size
was selected based on season and expected body condi-
tion to ensure a complete intramuscular (i.m.) injection.
All darts had a Recco® tracking device (Recco AB,
Lidingö, Sweden) and all darts were recovered. Xylazine
was reversed with atipamezole (Antisedan®, 5 mg/mL
Orion Pharma Animal Health, Turku, Finland) at a dose
ratio of 0.1 mg per mg xylazine intravenously (i.v.) or
i.m. Atipamezole was administered either for early rever-
sal of xylazine at 13–31 min (mean 21 min) after darting
or i.v. at 40–60 min after darting when etorphine was re-
versed with diprenorphine (Large Animal Revivon® 3 mg/ml,
Novartis Animal Health, Litlington, UK) at a dose ratio of
1.34 mg per mg etorphine giving a total dose of 4.5 mg. The
animals receiving atipamezole i.m. were not given additional
atipamezole i.v. at the time of opioid reversal.
Variables recorded included time from sighting to suc-
cessful darting (chase time), time from darting to recum-
bency (induction time), time from recumbency to reaching
and handling the animal (capture time), time from darting
until reversal agent was administered (reversal time) and
time from administration of diprenorphine to standing
(recovery time). These variables are summarised in
Table 1. Induction and recovery quality were assessed
subjectively. Moose found in lateral recumbency at
capture, were placed in sternal recumbency. For those
with the head on the ground, snow was cleared from
Table 1 Time variables recorded and compared for each treatment
Variable Units Oxygen treatment Atipamezole i.m. Atipamezole i.v. Combination treatment
Chase time minutes 3.6 ± 3.2 (1–12) 3.8 ± 2.3 (1–8) 4.6 ± 3.0 (1–9) 3.4 ± 1.8 (2–7)
Induction time minutes 7.1 ± 3.6 (2–13) 7.2 ± 4.6 (2–15) 7.8 ± 4.3 (4–15) 9.1 ± 4.6 (3–16)
Capture time minutes 6.5 ± 3.3 (3–13) 6.2 ± 1.7 (4–8) 5.8 ± 1.6 (3–9) 5.3 ± 1.9 (3–8)
Reversal time minutes 34.4 ± 3.4 (31–41) 46.5 ± 9.2 (40–53) 34.3 ± 2.0 (32–38) 34.7 ± 3.9 (30–41)
Recovery time seconds 122 ± 24 (93–160) 131 ± 27 (100–170) 109 ± 17 (72–125) 109 ± 18 (90–135)
Time from sighting to successful darting (chase time), time from darting to recumbency (induction time), time from recumbency to reaching and handling the
animal (capture time), time from darting until reversal agent was administered (reversal time) and time from administration of diprenorphine to standing
(recovery time) in free-ranging moose (Alces alces) darted from helicopter with etorphine-acepromazine-xylazine. Mean ± SD (range) values are presented.
Lian et al. Acta Veterinaria Scandinavica 2014, 56:51 Page 3 of 8
http://www.actavetscand.com/content/56/1/51around the nostrils. Pulse rate was measured by palpa-
tion of the auricular artery, respiration rate by count-
ing thoracic elevations and rectal temperature with a
digital thermometer. Capillary refill time (CRT) and mucus
membrane color were monitored from the mucus mem-
brane of the eye. Jaw tone was used to assess muscle tone
and classified as absent, tense or rigid. Palpebral reflex
(absent, present or spontaneous) and presence of move-
ment were also monitored. All variables were measured
when the animal was first approached after recumbency,
and repeated 15 min later. Rectal temperature was not re-
peated in female moose, since they were rectally palpated
to establish reproductive status.
Degree of central nervous system depression was clas-
sified as level I (mildly affected, voluntary movement
and intact reflexes), level II (no voluntary movement and
intact reflexes), level III (unconsciousness, depressed re-
flexes, muscular relaxation) and level IV (ceased respir-
ation, dilated pupils). This evaluation was assessed at
capture, and again 15 minutes after treatment.
As soon as possible after capture and 15 min after
start of treatment an arterial blood sample was collected
anaerobically from the auricular artery, using a pre-
heparinized syringe (Portex® Arterial blood gas sampling
kit, Smiths Medical ASD, New Hampshire, USA) and a
23-gauge needle. The sample was analyzed immedi-
ately using an i-STAT®1 Portable Clinical Analyzer and
i-STAT® CG4+ and 6+ cartridges (Abbott Laboratories,
Illinois, USA). The analyzer was kept in an insulated box
with warm water bottles to maintain the temperature
between 16 - 30°C.
Measured variables included pH, PaO2, partial pressure
of carbon dioxide (PaCO2) and lactate. PaO2, PaCO2 and
pH were corrected based on rectal temperature. The ini-
tial temperature was used for correction of both samples
in all animals. Calculated values included bicarbonate
(HCO3
−), hemoglobin oxygen saturation (SaO2) and base
excess (BE).
The alveolar-arterial oxygen tension difference (P(A-a)O2)
prior to oxygen insufflation was estimated for the
temperature corrected values, based on calculation of the
alveolar oxygen tension (PAO2) calculated from the alveo-
lar gas equation [PAO2 = FiO2 (PB - PH2O ) - (PaCO2/RQ)],where FiO2 = fraction of inspired oxygen (0.21) and PH2O =
saturated vapor pressure for water at 37°C (47 mmHg).
The respiratory quotient (RQ) was assumed to be 1 for
moose [24]. P(A-a)O2 was not calculated after oxygen insuf-
flation, because the FiO2 was then unknown.
For the first part of the study moose were randomly
assigned to one of three different treatments, intranasal
oxygen insufflation from a portable oxygen cylinder at a
flow rate of 4 L/min (oxygen group), early administra-
tion of atipamezole i.m. with a 20 gauge needle and 3 ml
syringe in femoral muscles (i.m. group) or an early ad-
ministration of atipamezole i.v. with a 20 gauge needle
and 3 ml syringe in the jugular vein (i.v. group). Having
completed 10 animals with intranasal oxygen treatment,
six animals with atipamezole i.m. and 10 animals with
atipamezole i.v., it was decided to include a fourth group
treated with a combination of intranasal oxygen at a flow
rate of 4 L/min and atipamezole intravenously (combin-
ation group).
The oxygen nasal line was inserted 10 cm into one of
the nostrils and fixated with a clothes peg or tape. Fif-
teen min after starting treatment, a second arterial blood
sample was collected and analysed in the same way.
Venous blood samples for serum biochemistry were
collected from the jugular vein before treatment was
initiated.
Statistics were done using JMP® (SAS Campus Drive,
North Carolina, USA). The Shapiro-Wilk test for nor-
mality was used to confirm that the data (recovery time,
PaO2, PaCO2, pH, lactate, pulse and respiratory rates)
within each treatment group was normally distributed.
Within each group, the difference between the first and
second sample was analyzed using a two-tailed paired t-
test. A simple Bonferroni adjustment was used (0.05/7),
and therefore P values less than 0.007 were considered
significant. To compare the mean increase in PaO2 from
the first to the second sample from the four groups,
oneway ANOVA (Analysis of Variance) was used. Com-
parison for all pairs was done using Tukey-Kramer HSD.
Simple descriptive statistics including mean, standard
deviation and range for all physiological variables was
calculated in Microsoft® Excel® 2007. Mean ± SD (range)
values are presented.
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Ambient temperature was −6.7 ± 5 (−19.0 – 2.3)°C. The
barometric pressure ranged from 723 to 781 mmHg.
The induction time was 7.5 ± 4 (2–16) minutes. At
capture, 21 moose showed no movement, 11 moved
their head and one moved its head and neck. Palpebral
reflex was absent in 14 moose, present in 16 moose and
three moose were blinking spontaneously. Muscle tone
was absent in 17 moose, while 16 moose had muscle
tone intact. Generalized tremors were observed in two
animals with muscle tone. All moose were sufficiently
immobilized for handling with a moderate degree of
central nervous system depression (stage I to III) and
their heads were lowered. All animals were alive four
months after capture. Chase time, capture time, induc-
tion time, reversal time and recovery time for each
group are presented in Table 1. Each group is presented
with physiological variables and blood gasses before and
after 15 minutes of treatment in Table 2.
The initial PaO2 for all moose was 62 ± 17 (26–99)
mmHg. Twenty-six out of 33 moose had a PaO2 <
80 mmHg (26–77 mmHg) before treatments were initi-
ated. Ten animals had a PaO2 between 40 – 60 mmHg
and three animals had a PaO2 < 40 mmHg. The P(A-a)O2
was 30 ± 12 (7–58) mmHg before treatments (sample 1).
Lactate was 6.8 ± 4.1 (0.6 - 18.2) mmol/L in the first
sample, and all four groups showed a significant decline in
lactate from the first to the second sample. PaCO2 was >
45 mmHg in all animals, and in 14 animals PaCO2 was be-
tween 60 – 80 mmHg. Twenty-nine animals had a pH <
7.35 before treatment, and of these, five had a pH < 7.20.
In the i.m. group two out of six animals had an in-
crease in PaO2, with 14 and 58 mmHg after treatment. In
three animals PaO2 decreased. No increase in movement
was observed, and the degree of central nervous system
depression was assessed to be the same through the
immobilization period. All animals in the i.m. group had
poor recoveries, with trouble standing.
Two outliers were removed from the i.v. group, one which
fell into lateral recumbency during the immobilization
period and one in which intravenous injection was not
complete and partly administrated subcutaneously. PaO2 in-
creased significantly (P = 0.004) after treatment, with a mean
increase of 12 mmHg. However, six animals still had low
PaO2-values (PaO2 < 80 mmHg). At the time of the second
sample palpebral reflex or spontaneous blinking were
present in all animals. They regained muscle tone, moved
their head, and were able to hold the head elevated
from the ground. All animals experienced smooth re-
coveries. This was also seen in the combination group,
where all animals also regained palpebral reflex or
were blinking spontaneously, regained muscle tone,
moved their head and held it elevated from the ground,
and had smooth recoveries.There was no significant difference in recovery time
among groups, but a trend toward faster recovery for
moose in the two groups treated with an early intraven-
ous reversal of xylazine. The mean increase in PaO2 be-
tween samples was significantly (P = 0.0008) different
between the intranasal oxygen group and the two atipa-
mezole groups, while the mean increase in PaO2 did not
differ significantly between the intranasal oxygen group
and the combination group. Mean increase of PaCO2 was
not significantly different in any of the groups.
Discussion
This study documented the effect of intranasal oxygen
insufflation and early reversal of xylazine with atipame-
zole on improving arterial oxygenation in chemically
immobilized free-ranging moose.
The mild to severe hypoxemia seen in 26 out of 33
moose was expected based on a previous report of hyp-
oxemia in moose immobilized with this combination [9].
At sea level in normally ventilating mammals breathing
air, PaO2 is between 80 – 100 mmHg [12]. In our study,
seven out of 33 moose had an assumed normal PaO2 in
the first arterial blood sample. There was evidence of im-
paired oxygen exchange before onset of treatment, with a
P(A-a)O2 of 30 ± 12 (7–58) mmHg. However, with values
ranging from 7 – 58 mmHg, this was not evident in all
moose. The concurrent high respiratory rate might have
been a sign of superficial breathing, and thereby increasing
dead space ventilation and lowering the amount of alveo-
lar oxygen. Since the study was conducted at low altitudes,
reduced inspired pressure of oxygen can be ruled out as
primary cause of hypoxemia. Recognized side effects of
opioid and alpha-2 adrenoceptor agonists in ruminants
are hypoventilation and intrapulmonary factors like in-
creased diffusion barrier, lower V/Q ratio and increased
physiological shunt [12,25,26]. Since all individuals were
hypercapnic in the first sample with an increased mean
P(A-a)O2, hypoventilation and intrapulmonary factors
were likely major contributors to the hypoxemia in the
immobilized moose in this study.
Hypoxemia in large animals may also be a result of re-
cumbency. In conscious horses [27] and cattle [28] it has
been shown that PaO2 decreases when the animals pos-
ition is changed from sternal to lateral or dorsal pos-
ition. Even in sternal recumbency the abdominal viscera
may compress the diaphragm, leading to low V/Q mis-
match which result in venous admixture [12].
In the two treatment groups given oxygen, PaO2, in-
creased in all individuals and there was a significant in-
crease in the mean PaO2 between the first and the
second sample. PaCO2 also increased significantly after
oxygen treatment. This has been reported previously in
wild cervids receiving oxygen supplementation [14,16,17]
Ventilation is mainly controlled by central chemoreceptors
Table 2 Physiological variables from immobilized moose
Oxygen Oxygen Atipamezole i.m. Atipamezole i.m. Atipamezole i.v. Atipamezole i.v. Combination Combination
Before After 15 min of O2 Before 15 min after Before 15 min after Before 15 min after
Variable Unit N T1: 7–27
minutes
T2: 22–45 minutes N T1: 11–29 minutes T2: 27–44 minutes N T1: 11–29 minutes T2: 26–45 minutes N T1: 13–30 minutes T2: 28–45 minutes
Rectal temp C 10 38.2 ± 0.7
(37.5 - 39.4)
Not recorded 6 37.8 ± 0.3 (37.3 - 38.0) Not recorded 8 38.1 ± 0.8
(37.7 - 39.3)
Not recorded 7 38.1 ± 0.2
(37.9 - 38.4)
Not recorded
Pulse rate Beats/min 10 50 ± 9 (40–66) 38 ± 7 (24–48)‡ 6 44 ± 6 (36–52) 37 ± 4 (30–40)‡ 8 47 ± 9 (36–60) 46 ± 7 (40–56) 7 50 ± 15 (36–64) 48 ± 14 (22–64)
Resp rate Breaths/min 10 34 ± 9 (12–45) 29 ± 8 (18–44) 6 29 ± 3 (24–32) 25 ± 4 (20–28) 8 32 ± 6 (20–40) 24 ± 6 (16–36)‡ 7 30 ± 6 (20–36) 23 ± 8 (12–36)
Capillary
refill time
seconds 8 1.3 ± 0.5 (1–2) 1 ± 0 (1) 6 1.5 ± 0.5 (1–2) 1 ± 0 (1) 8 1.9 ± 0.3 (1–2) 1 ± 0 (1) 7 1.6 ± 0.5 (1–2) 1 ± 0 (1)
Color mucus
membrane
1-4† 8 3 (1–4) 3 (2–4) 6 2 (1–3) 3 (2–4) 8 3 (2–4) 4 (3–4) 7 3 (2–4) 4 (3–4)
PaO2* mmHg 10 67 ± 19 (32–99) 127 ± 38 (63–185)
‡ 6 61 ± 19 (40–86) 67 ± 23 (41–109) 8 55 ± 18 (26–84) 67 ± 14 (46–86)‡ 7 61 ± 13 (47–80) 96 ± 20 (75–124)‡
PaO2* Kpa 10 8.9 ± 2.5
(4.2 - 13.2)
16.9 ± 5.0 (8.4 - 24.7)‡ 6 8.1 ± 2.5 (5.3 - 11.5) 8.9 ± 3.1 (5.5 - 14.5) 8 7.3 ± 2.4 (3.5 - 11.2) 8.9 ± 1.9 (6.1 - 11.5)‡ 7 8.1 ± 1.8 (6.3 - 10.7) 12.8 ± (10.0 - 16.6)‡




6 63.4 ± 8.7 (50.0 - 71.8) 67.3 ± 6.4 (58.7 - 75.5) 8 60.0 ± 9 (48.2 - 73.8) 62.2 ± 8.1
(52.1 - 77.1)
7 57.6 ± 7.7 (48.5 - 67.4) 68.2 ± 8.1
(54.6 - 76.8)‡
PaCO2* kPa 10 7.5 ± 1.2
(6.3 - 10.2)
9.1 ± 1.8 (6.9 - 12.1)‡ 6 8.5 ± 1.2 (6.7 - 9.6) 9.0 ± 0.9 ( 7.8 - 10.1) 8 8.0 ± 1.2 (6.4 - 9.8) 8.3 ± 1.1 (6.9 - 10.3) 7 7.8 ± 1.0 (6.5 - 9.0) 9.1 ± 1.1
(7.3 - 10.2)‡
pH* 10 7.28 ± 0.07
(7.15 - 7.37)
7.27 ± 0.09 (7.17 - 7.42) 6 7.26 ± 0.05 (7.20 - 7.33) 7.29 ± 0.03
(7.25 - 7.34)




7 7.23 ± 0.13(7.01 - 7.37) 7.24 ± 0.1
(7.06 - 7.38)
Lactate mmol/L 10 7.1 ± 4.3
(2.4 - 16.6)
4.9 ± 3.6 (1.6 - 13.5)‡ 6 5.3 ± 1.3 (3.9 - 7.4) 3.3 ± 0.5 (2.7 - 3.9)‡ 8 5.0 ± 2.7 (3.3 - 11.5) 2.5 ± 0.8 (1.5 - 4.0)‡ 7 9.1 ± 6.2 (0.6 - 18.2) 5.6 ± 4.6
(0.6 - 14.4)‡
Physiological variables from free-ranging moose (Alces alces), during chemical immobilization with etorphine-acepromazine-xylazine, delivered by dart syringe from helicopter. Mean± SD (range) values are presented for all variables,
except color of mucus membrane, where median (range) is presented. †: 1: blue, 2: blue-pink, 3: pale pink, 4: pink. *: temperature corrected values. ‡: significant difference after treatment. T1 is time from darting
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http://www.actavetscand.com/content/56/1/51in the medulla sensitive to pH and PaCO2 and peripheral
chemoreceptors in the aortic and carotid bodies sensitive
to pH and PaO2. However, the response of these chemore-
ceptors to PaO2, PaCO2 and pH is depressed by opioids and
sedatives. Further, the increased PaO2 levels arising from
the oxygen treatment diminishes the respiratory drive
caused by hypoxemia, resulting in an increased level of
hypoventilation and PaCO2 [12]. This probably resulted in
the significant increase in PaCO2 seen in the two groups
given oxygen. The Haldane effect may also have contrib-
uted to the significant increase in PaCO2 in these groups,
since increasing oxygenation of blood decreases the cap-
acity for carbon dioxide transport. When the arterial oxy-
genation improves in the hypoxemic patient, the affinity of
carbon dioxide for hemoglobin decreases and carbon diox-
ide is easily displaced. This causes the overall PaCO2 in the
blood to increase as the arterial oxygenation improves
[14,16,17,29]. Studies on elk [17] and bongo antelopes
(Tragelaphus eurycerus) [20] found the same effect with a
concurrent decreased respiratory rate. In the current study,
there was a significantly decreased respiratory rate in the
i.v. group. Interestingly, in the two atipamezole groups that
did not receive intranasal oxygen, the increase in PaCO2 be-
tween samples was not significant. However, the four
groups were not significantly different when compared sta-
tistically. To reduce the high PaCO2 levels found with this
drug protocol, endotracheal intubation and intermittent
positive-pressure ventilation would be necessary [30].
When atipamezole was administered intramuscularly
only one animal showed a satisfactory increase in arterial
oxygenation, from 51 mmHg to 109 mmHg. Further-
more, there was no change in movement, and only a
slight improvement in mucus membrane color and ca-
pillary refilling time was observed in the animals. This
was likely a result of the degree of central nervous sys-
tem depression remaining the same, and, therefore few
changes in the alpha-2 adrenoceptor agonist effects on
circulation. The lack of effect in this treatment group
was probably a result of insufficient time and effective-
ness for atipamezole to be absorbed from the muscle.
This is supported by poor recoveries with difficulty
standing and avoiding trees in this group, likely due to
residual effects of xylazine. Based on these findings we
decided to discontinue the i.m. group after a sample size
of six animals.
There was a significant increase in PaO2 between the
first and second sample when atipamezole was adminis-
tered intravenously. By reversing the xylazine compo-
nent of the immobilization protocol, moose went from
level II – III of central nervous depression to level I. A
more superficial level of immobilization eliminated some
of the drug induced depression on circulation and breath-
ing reflexes. After antagonizing xylazine, the moose were
able to hold their head elevated off the ground. Improvedhead holding behavior ensured clear airways and probably
facilitated gas exchange. Antagonizing the cardiovascular
side effects from xylazine improved mucus membrane
color and capillary refilling time, reflecting better circula-
tion. Better circulation may have improved pulmonary
perfusion by increasing the V/Q ratio, leading to the sig-
nificantly increased PaO2. However, only two out of eight
animals improved their PaO2 values high enough to be
considered as normal values.
In a field situation, with limited personnel and equip-
ment, chemical methods for improving respiration would
be advantageous. In this study, early reversal of xylazine
appears to improve gas exchange. Alpha-2 adrenoceptor
agonists can have serious side effects including bloat, re-
gurgitation and aspiration, leading some authors to not
recommend the combination of xylazine with opioids for
immobilization of wild ruminants [6], however early rever-
sals of these drugs would allow for their beneficial effects
during induction, while avoiding potential side effects dur-
ing the immobilization period.
Arterial oxygenation was not significantly different be-
tween the oxygen group and the combination group. Al-
though, in the combination group moose regained palpebral
reflex and muscle tone and were able to hold their head off
the ground, similar to moose in the i.v. group. The two
groups with early intravenous reversal of xylazine had sig-
nificantly improved PaO2 values despite no change in PaCO2,
and improved head holding behavior, which suggest better
gas exchange with a decrease in degree of central nervous
system depression. Capillary refilling time normalized in
both groups, and color of mucus membranes improved in
both groups. By reversing xylazine, the vascular side
effects were probably decreased, leading to an im-
proved circulation [22].
Acidemia was documented in most animals, likely
caused both by hypercapnia and anaerobic metabolism.
An increase in blood CO2 decreases pH, which de-
creases hemoglobin affinity for oxygen (Bohr Effect).
The resulting release of oxygen is beneficial for hypoxic
tissues. However, this negatively influences pulmonary
hemoglobin oxygen uptake. And, a severe acidemia de-
creases myocardial contractility and predisposes to ar-
rhythmias [31]. The pH decreased over time in the
oxygen group. In the two groups with an early intraven-
ous reversal of xylazine pH had a trend of increasing
over time, however, this was not significant. Acidemia
has been reported from other studies on oxygen supple-
ment to free-ranging ungulates [8,17,19].
Lactate is an anaerobic metabolic product, and the
plasma concentration increases when tissue is deprived
of oxygen [31]. In a study of moose immobilized with
etorphine, elevated lactate levels were positively corre-
lated with physical exertion (snow depth) and short in-
duction time (dose dependent) [32]. Elevated lactate
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ing to capture myopathy [33]. Two independent studies,
found hyperlactemic moose immobilized with both etor-
phine alone [32] and the combination of etorphine, ace-
promazine and xylazine [9]. Mortality due to capture
myopathy has not been reported with the etorphine
protocol used in Norway. However, with the etorphine,
acepromazine and xylazine protocol used in Sweden,
there have been at least two deaths related to capture
myopathy [1] . All animals in this study significantly de-
creased lactate levels between the first and the second
sample. The elevated lactate level was probably related
to lactic acid accumulation due to muscle activity during
darting and induction. A decreased delivery of oxygen to
tissues due to low PaO2 would also contribute to the high
lactate levels found in this study. However, the decrease
in lactate concentration over time seen in this study in-
dicates that the cellular environment in the muscle tis-
sue improved [31].
Conclusions
This study showed that moose immobilized with etor-
phine, acepromazine and xylazine have low arterial oxygen-
ation, and varying degree of respiratory and metabolic
acidemia. Nasal insufflation with oxygen proved to be a sim-
ple and effective technique to improve arterial oxygenation.
Further, this study showed that when the immobilizing
drugs for moose consist of a potent opioid combined
with xylazine, it is beneficial for the arterial oxygenation
to reverse xylazine immediately after the animal be-
comes recumbent. Atipamezole should be administered
intravenously, to have a significant effect on PaO2.
The recommended treatment for hypoxemia in moose
immobilized with etorphine, acepromazine and xylazine
is the combination of intranasal oxygen and an early
intravenous reversal of the alpha-2 adrenoceptor agonist.
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